Anti-cytokeratin CAM 5.2 does not act as a surrogate of the cytokeratin 8/18 monoclonal antibody. Comment on: “Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma”, in J Cutan Pathol 2009; 36: 54
2010 ◽
Vol 37
(10)
◽
pp. 1123-1124
◽
2011 ◽
Vol 2011
◽
pp. 53-54
2009 ◽
Vol 36
(5)
◽
pp. 543-547
◽
Keyword(s):
2010 ◽
Vol 37
(7)
◽
pp. 744-750
◽
2012 ◽
Vol 39
(12)
◽
pp. 1110-1110
◽
Keyword(s):
2001 ◽
Vol 125
(6)
◽
pp. 799-802
◽
2011 ◽
Vol 38
(11)
◽
pp. 884-888
◽
Keyword(s):
2018 ◽
Vol 3
(02)
◽
2011 ◽
Vol 111
(1)
◽
pp. e43-e44